Hakimoğlu Sedat, Tuzcu Kasım, Davarcı Işıl, Karcıoğlu Murat, Ayhan Tuzcu Esra, Hancı Volkan, Aydın Suzan, Kahraman Hilal, Elbeyli Ahmet, Turhanoğlu Selim
Department of Anesthesiology and Reanimation, Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey.
Department of Anesthesiology and Reanimation, Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey.
Kaohsiung J Med Sci. 2016 Feb;32(2):80-5. doi: 10.1016/j.kjms.2016.01.009. Epub 2016 Feb 23.
During surgery, changes in intraocular pressure (IOP) can be observed resulting from several factors, such as airway manipulations and drugs used. We aimed to investigate the effects of sugammadex and neostigmine on IOP, hemodynamic parameters, and complications after extubation. Our study comprised 60 patients, aged 18-65 years, with a risk status of the American Society of Anesthesiologists I-II who underwent arthroscopic surgery under general anesthesia. The patients were randomly assigned into two groups. At the end of the surgery, the neuromuscular block was reversed using neostigmine (50 μg/kg) plus atropine (15 μg/kg) in Group 1, and sugammadex (4 mg/kg) in Group 2. Neuromuscular blockade was monitored using acceleromyography and a train-of-four mode of stimulation. IOP was measured before induction and at 30 seconds, 2 minutes, and 10 minutes after extubation. A Tono-Pen XL applanation tonometer was used to measure IOP. This showed that elevation in IOP of patients reversed using sugammadex was similar to that recorded in patients reversed using neostigmine-atropine. When heart rate was compared, there was a significant difference between basal values and those obtained at 30 seconds and 10 minutes after extubation in the neostigmine-atropine group. Extubation time (time from withdrawal of anesthetic gas to extubation) was significantly shorter in the sugammadex group (p = 0.003) than in the neostigmine-atropine group. The postextubation IOP values of the sugammadex group were similar to the neostigmine-atropine group. Extubation time (time from withdrawal of anesthetic gas to extubation) was significantly shorter in the sugammadex group (p = 0.003) than in the neostigmine-atropine group.
手术过程中,眼内压(IOP)会因多种因素发生变化,如气道操作和所用药物。我们旨在研究舒更葡糖钠和新斯的明对眼压、血流动力学参数及拔管后并发症的影响。我们的研究纳入了60例年龄在18至65岁之间、美国麻醉医师协会风险分级为I-II级、在全身麻醉下行关节镜手术的患者。患者被随机分为两组。手术结束时,第1组使用新斯的明(50μg/kg)加阿托品(15μg/kg)逆转神经肌肉阻滞,第2组使用舒更葡糖钠(4mg/kg)。使用加速度肌电图和四个成串刺激模式监测神经肌肉阻滞。在诱导前以及拔管后30秒、2分钟和10分钟测量眼压。使用Tono-Pen XL压平眼压计测量眼压。结果显示,使用舒更葡糖钠逆转的患者眼压升高情况与使用新斯的明-阿托品逆转的患者记录情况相似。比较心率时,新斯的明-阿托品组基础值与拔管后30秒和10分钟时的值之间存在显著差异。舒更葡糖钠组的拔管时间(从停止麻醉气体到拔管的时间)明显短于新斯的明-阿托品组(p = 0.003)。舒更葡糖钠组拔管后的眼压值与新斯的明-阿托品组相似。舒更葡糖钠组的拔管时间(从停止麻醉气体到拔管的时间)明显短于新斯的明-阿托品组(p = 0.003)。